More Newron Pharmaceuticals S.p.a. news Newron Pharmaceuticals S.p.a.SIX: NWRN Newron Secures Up to EUR 38 Million to Advance Phase III Evenamide Program Feb 16, 2026 at 4:45 PM UTC · Issued by Newron Pharmaceuticals S.p.a. As issuedPlain English Watch Newron Pharmaceuticals explain it↗Newron Pharmaceuticals S.p.A. (0QOI) Q4 2025 Earnings Call · Replay · Mar 24The original release is unavailable here.
